Daily statistics
"Orchard Therapeutics Presents New Interim Data from OTL-203 Proof-of-concept Study for MPS-I"
about Orchard Therapeutics plc
Notified: 06:00 EDT at $9.52
"Resonant Botanicals Launches New 1000mg Topical Formula"
about Resonant Inc.
Notified: 07:02 EDT at $2.27
"ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting"
about ESSA Pharma Inc.
Notified: 07:30 EDT at $4.70
"Seelos Therapeutics Receives Rare Pediatric Disease Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome"
about Seelos Therapeutics, Inc.
Notified: 07:30 EDT at $0.78
"Jounce Therapeutics to Present First Preclinical Data on Anti-CCR8 Antibody JTX-1811 and Vopratelimab Translational Data at the American Ass..."
about Jounce Therapeutics, Inc.
Notified: 08:01 EDT at $4.44
"Rubius Therapeutics to Present Preclinical Data for RTX-321, a Red Cell Therapeutic™ Oncology Product Candidate for HPV-Positive Cancers at ..."
about Rubius Therapeutics, Inc.
Notified: 08:01 EDT at $6.00
"Integra LifeSciences Announces Positive Clinical Results for Integra® Bilayer Wound Matrix (IBWM)"
about Integra LifeSciences Hold..
Notified: 08:01 EDT at $47.29
"Lipocine Announces Presentations on TLANDO™ at AUA Virtual Experience 2020"
about Lipocine Inc.
Notified: 08:01 EDT at $0.75
"Pfizer’s New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Pha..."
about Pfizer, Inc.
Notified: 08:02 EDT at $37.60
"SunPower's Planned Maxeon Solar Technologies Spin-Off Receives Key Regulatory Approval"
about SunPower Corporation
Notified: 08:06 EDT at $6.40
"UroGen Pharma Announces First Presentation of Data from Phase 2b Study of UGN-102 in Patients with Difficult to Treat Type of Bladder Cancer"
about UroGen Pharma Ltd.
Notified: 09:01 EDT at $24.87
"Editas Medicine Presents Pre-Clinical Data Supporting the use of CRISPR-Cas12a to Edit Induced Pluripotent Stem Cells for the Development of..."
about Editas Medicine, Inc.
Notified: 09:20 EDT at $24.47
"CureDuchenne Applauds Pfizer’s Encouraging Data from Phase Ib Mini-Dystrophin Gene Therapy Trial for Duchenne Muscular Dystrophy"
about Pfizer, Inc.
Notified: 09:28 EDT at $37.97
"Atara Biotherapeutics Announces Presentation of Late-Breaking Preclinical Data on ATA2271, a Next-Generation Autologous CAR T Immunotherapy ..."
about Atara Biotherapeutics, In..
Notified: 09:39 EDT at $9.67
"Golden Bull Limited is in Compliance with Nasdaq Minimum Bid Requirement and Completed $2.6 Million Financing"
about Golden Bull Limited
Notified: 14:01 EDT at $1.10
Notice: Price change for each notified stock are being tracked by Preticks after signal notification and given stock price change analysis in this daily summary is being calculated accordingly. You can explore details for each notified signal in daily detailed performance analysis page.
